| Income Statement |
| Operating Expenses | 1.06M |
|
| Research and Development Expense | 178.00K |
| Selling, General and Administrative Expense | 880.00K |
| Operating Income | -1.06M |
| Net Income | -955.00K |
| Net Income Common Stock | -955.00K |
| Net Income Common Stock (USD) | -955.00K |
| Consolidated Income | -955.00K |
| Earnings per Basic Share | -0.14 |
| Earnings per Basic Share (USD) | -0.14 |
| Earnings per Diluted Share | -0.14 |
| Earning Before Interest & Taxes (EBIT) | -955.00K |
| Earning Before Interest & Taxes (USD) | -955.00K |
| Weighted Average Shares | 6.73M |
| Weighted Average Shares Diluted | 6.73M |
| Balance Sheet |
| Cash and Equivalents | 16.26M |
| Cash and Equivalents (USD) | 16.26M |
| Trade and Non-Trade Receivables | 217.00K |
| Current Assets | 16.58M |
| Total Assets | 16.58M |
| Current Liabilities | 7.84M |
| Total Liabilities | 7.99M |
| Accumulated Retained Earnings (Deficit) | -399.60M |
| Shareholders Equity | 8.60M |
| Shareholders Equity (USD) | 8.60M |
| Deferred Revenue | 150.00K |
| Liabilities Non-Current | 150.00K |
| Trade and Non-Trade Payables | 7.84M |
| Cash Flow |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.01M |
| Net Cash Flow from Operations | -1.01M |
| Share Based Compensation | 22.00K |